Literature DB >> 10327081

Critically sized osteo-periosteal femoral defects: a dog model.

K H Kraus1, S Kadiyala, H Wotton, A Kurth, M Shea, M Hannan, W C Hayes, C A Kirker-Head, S Bruder.   

Abstract

A 21-mm defect was created in 1 femoral diaphysis each of 15 dogs. Periosteum as well as a cylinder of bone was removed, and the defect was stabilized with a bone plate. Twelve of the defects were filled with an equal volume of autogenous cancellous bone harvested from the ipsilateral ilium. Three defects were left untreated. Cranial to caudal radiographs were taken postoperatively and every 4 weeks for 16 weeks. The radiographs were evaluated for healing using two ordinal scales. At 16 weeks, the dogs were euthanized and the femurs harvested for biomechanical testing and histologic evaluation. Both operated and contralateral not operated femurs were mechanically tested to failure in torsion, and load at failure and stiffness were calculated. All dogs tolerated the procedure well, and were using the operated limb within 1 or 2 days postoperatively. There were no complications noted during the 16 weeks of the study. Unfilled defects did not heal and became atrophic nonunions. The defects filled with autogenous cancellous bone healed in a consistent pattern of consolidation, incorporation, and remodeling, with uniform increases of both ordinal scales used. The femoral cortex opposite the bone plate demonstrated most mature remodeling, evident both radiographically as well as histologically. Unoperated femurs failed at 13.61 +/- 3.88 N-m and grafted femurs failed at 2.96 +/- 1.3 N-m, which was 23% of the measurement of the unoperated femur. Relative stiffness of the unoperated femurs was 5974 +/- 4316 N-m2/radian, and grafted femurs had a relative stiffness of 642 +/- 561 N-m2/radian, which was 10.4% of the measurement of unoperated femur. This model proved to be a critically sized defect, which when left unfilled resulted in an atrophic nonunion, and when filled with cancellous bone resulted in a consistent healing pattern.

Entities:  

Mesh:

Year:  1999        PMID: 10327081     DOI: 10.1080/089419399272674

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  7 in total

1.  BMP-silk composite matrices heal critically sized femoral defects.

Authors:  C Kirker-Head; V Karageorgiou; S Hofmann; R Fajardo; O Betz; H P Merkle; M Hilbe; B von Rechenberg; J McCool; L Abrahamsen; A Nazarian; E Cory; M Curtis; D Kaplan; L Meinel
Journal:  Bone       Date:  2007-04-27       Impact factor: 4.398

2.  Influence of gender and fixation stability on bone defect healing in middle-aged rats: a pilot study.

Authors:  Manav Mehta; Georg N Duda; Carsten Perka; Patrick Strube
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

3.  Use of coccygeal vertebra autograft and platelet-rich plasma for treating a distal radial nonunion fracture in a small-breed dog.

Authors:  Jin-Young Choi; Hun-Young Yoon
Journal:  Can Vet J       Date:  2022-07       Impact factor: 1.075

4.  Angle stable nails provide improved healing for a complex fracture model in the femur.

Authors:  Meghan R Kubacki; Christopher A Verioti; Savan D Patel; Adam N Garlock; David Fernandez; Patrick J Atkinson
Journal:  Clin Orthop Relat Res       Date:  2013-09-19       Impact factor: 4.176

5.  Short term outcomes and complications of distal ulnar ostectomy in 23 juvenile dogs with carpal valgus secondary to discordant radial-ulnar physeal growth.

Authors:  Scott Christopher
Journal:  Front Vet Sci       Date:  2022-09-09

6.  Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2.

Authors:  Christoph Wallner; Henriette Jaurich; Johannes Maximilian Wagner; Mustafa Becerikli; Kamran Harati; Mehran Dadras; Marcus Lehnhardt; Björn Behr
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

Review 7.  An overview of de novo bone generation in animal models.

Authors:  Takashi Taguchi; Mandi J Lopez
Journal:  J Orthop Res       Date:  2020-09-23       Impact factor: 3.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.